A Prospective Observational Study Evaluating the Correlation of <b><i>c-MET</i></b> Expression and <b><i>EGFR</i></b> Gene Mutation with Response to Erlotinib as Second-Line Treatment for Patients with Advanced/Metastatic Non-Small-Cell Lung Cancer - Retracted Article | RetractBase